Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP570771.RAXg3y3082bnFvqrAOINQNFAPhzIlBiC1k3Abo0j53dX0130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570771.RAXg3y3082bnFvqrAOINQNFAPhzIlBiC1k3Abo0j53dX0130_provenance.
• NP363743.RATFf_IGckX5rhHBIqqzU3j3ea0BDbV6r1LdLGl6nH82g130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363743.RATFf_IGckX5rhHBIqqzU3j3ea0BDbV6r1LdLGl6nH82g130_provenance.
• NP610703.RAgYc3FzdRZnpX_oJGUUkhAMeUCsQdem3q9VuqX_J7rco130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610703.RAgYc3FzdRZnpX_oJGUUkhAMeUCsQdem3q9VuqX_J7rco130_provenance.
• NP589519.RAxy36IyHhqwRGcHkFFiKYCQ_n0icpWTe4sHigBykaNxY130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP589519.RAxy36IyHhqwRGcHkFFiKYCQ_n0icpWTe4sHigBykaNxY130_provenance.
• NP478053.RAC4ZQVJM30VqOwA0bkhLIyQVNUCJuIEQ6tCfU0CzBBF0130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478053.RAC4ZQVJM30VqOwA0bkhLIyQVNUCJuIEQ6tCfU0CzBBF0130_provenance.
• NP476762.RA-3iYyhArGGqnB4jhnCES_znZ63b8-fJ-p3mBFnAkVfY130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476762.RA-3iYyhArGGqnB4jhnCES_znZ63b8-fJ-p3mBFnAkVfY130_provenance.
• NP476862.RA48T8xOq9jEOQrIpX5CVCSsCm0nIg2whCic9p0JtBsyM130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476862.RA48T8xOq9jEOQrIpX5CVCSsCm0nIg2whCic9p0JtBsyM130_provenance.
• NP477953.RATHZUEQTmsJKqS_4p76pJ_Ck0NQF2jarHxpgndIWp8-g130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477953.RATHZUEQTmsJKqS_4p76pJ_Ck0NQF2jarHxpgndIWp8-g130_provenance.
• NP478245.RAfW5kbsDvRJvJSk2FASpu6Axn_hDdE44S_X296CFnWaI130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478245.RAfW5kbsDvRJvJSk2FASpu6Axn_hDdE44S_X296CFnWaI130_provenance.
• NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591649.RA5qyjL01jwzHNYbTL697-kK5UHWghOvyOUL3tV8cAzvA130_provenance.
• NP476817.RAIMkeVBGBbKlnluKnUApWY3RdwT7RxS9r8ZuuER1sARs130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476817.RAIMkeVBGBbKlnluKnUApWY3RdwT7RxS9r8ZuuER1sARs130_provenance.
• NP591638.RAWbnNXclxTEsHI-YN4tG21VsPx7J9QQbFm6E4a4-kt1s130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591638.RAWbnNXclxTEsHI-YN4tG21VsPx7J9QQbFm6E4a4-kt1s130_provenance.
• NP591642.RAXHerQhqPoBhm3fNrhJeGdD68pPOjWm_syEYg9FIsgZw130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591642.RAXHerQhqPoBhm3fNrhJeGdD68pPOjWm_syEYg9FIsgZw130_provenance.
• NP591646.RAflERKmThVXLbl4OMApLDDEmp-By6CtAokGCa4ySZpNw130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591646.RAflERKmThVXLbl4OMApLDDEmp-By6CtAokGCa4ySZpNw130_provenance.
• NP591647.RAb6x24gBNkLxa7HtNkDRY9V2KkZ88C3wudcjVcgrCliQ130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591647.RAb6x24gBNkLxa7HtNkDRY9V2KkZ88C3wudcjVcgrCliQ130_provenance.
• NP591651.RAZ2KO6YlSIIiQvizQxSSihqQOzDvWrfSImPbTCnWL0eo130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591651.RAZ2KO6YlSIIiQvizQxSSihqQOzDvWrfSImPbTCnWL0eo130_provenance.
• assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP477053.RALskumXve8ilE6w7Kubwx6dcFu5PtaNXdS4IFosQy2sw130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477053.RALskumXve8ilE6w7Kubwx6dcFu5PtaNXdS4IFosQy2sw130_provenance.
• NP591639.RAFyLO4YzuymByLPCIMBiNegJCDquckueSQADtEwuzrHQ130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591639.RAFyLO4YzuymByLPCIMBiNegJCDquckueSQADtEwuzrHQ130_provenance.
• NP591641.RAEnqTPzkHRnkGQP3FWWgD4VM6DeTMWGADkUBd_JYo7Is130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591641.RAEnqTPzkHRnkGQP3FWWgD4VM6DeTMWGADkUBd_JYo7Is130_provenance.
• NP476792.RAlPjunFsLIW8I66d0dx0Y5A12O_7oZchSpbCEJCh_rw8130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476792.RAlPjunFsLIW8I66d0dx0Y5A12O_7oZchSpbCEJCh_rw8130_provenance.
• NP477983.RAoRqX96TYU7WqDxDG6A1NEkzOtc2D8b1CdX4gHuKD1jQ130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477983.RAoRqX96TYU7WqDxDG6A1NEkzOtc2D8b1CdX4gHuKD1jQ130_provenance.
• NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478008.RAocoCXFN-nEIRsigdMrqB_Izz8GP5IrR89Ya10GxRpkk130_provenance.
• NP591645.RArlV4NOGynLDFkHeAEoMb26UHhf1iS2GqSPDyVRDcJ5A130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591645.RArlV4NOGynLDFkHeAEoMb26UHhf1iS2GqSPDyVRDcJ5A130_provenance.
• NP591648.RAhT4E-KY_p96hthytI7KXZ1uvaUe00cyUFa-wAWCQHMc130_assertion description "[Similar beneficial effects of alpha-IFN were noted in patients with malignant HES who lacked a detectable T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591648.RAhT4E-KY_p96hthytI7KXZ1uvaUe00cyUFa-wAWCQHMc130_provenance.